NovaBay Pharmaceuticals, Inc. (NBY)

Market Cap	4.50M
Revenue (ttm)	14.23M
Net Income (ttm)	-18.55M
Shares Out	37.83M
EPS (ttm)	-3.48
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	133,041,835
Open	0.150
Previous Close	0.120
Day's Range	0.105 - 0.259
52-Week Range	0.070 - 1.280
Beta	2.04
Analysts	n/a
Price Target	n/a
Earnings Date	May 9, 2024

About NBY

NovaBay Pharmaceuticals, Inc. develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health. The company also provides wound care ...

• Industry: Biotechnology
• Sector: Healthcare
• IPO Date: Oct 26, 2007
• Employees: 24
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: NBY

Financial Performance

In 2023, NBY's revenue was $14.73 million, an increase of 2.24% compared to the previous year's $14.40 million. Losses were -$16.70 million, 2.66% more than in 2022.